cholelithiasis
Conditions
Interventions
Group B:Ropivacaine paravertebral block: T7 paravertebral injection with 0.5% ropivacaine hydrochloride 14ml+normal saline 1ml
Group C:Ropivacaine & Betamethasone Single-injection Paravertebral Nerve Block: 0.5% ropivacaine hydrochloride 14ml + 2.5 mg compound betamethasone
Sponsors
Fuling Central Hospital, Chongqing City
Eligibility
Sex/Gender
All
Age
20 Years to 74 Years
Inclusion criteria
Inclusion criteria: 1. aged 18 to 75 years; 2. ASA physical status I–III; 3. scheduled for elective LC; 4. normal coagulation function; 5. weight >40 kg; 6. To be able to self-administer opioid via PCA, and 7. overnight admission.
Exclusion criteria
Exclusion criteria: Positive result of pregnancy test; vertebral anomalies; scoliosis; coagulopathy; local infection at planned injection sites; allergy to medications used in study; receiving anticoagulation medicationbody mass index (BMI) =36; severe hypertension (blood pressure >180/110mmgh); severe arrhythmia; ASA grade more than Class III; long-term oral anti-sympathetic nerve drugs; psychotropic substances and Valium sedative hypnotic substance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain assessment; | — |
Secondary
| Measure | Time frame |
|---|---|
| preoperative serum glucose level;postoperative serum glucose level;times of injection with parecoxib;Dosage of postoperative parecoxib;times of injection with tramadol;Dosage of postoperative tramadol;time of first postoperative rollover;time of first postoperative getting up;postoperative pain of wound; | — |
Countries
China
Contacts
Public ContactYun Xue
Fuling Central Hospital, Chongqing City
Outcome results
None listed